Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, Tamaulipas, México.
Am J Trop Med Hyg. 2010 Jul;83(1):15-20. doi: 10.4269/ajtmh.2010.09-0626.
The northern Chiapas onchocerciasis focus has undergone 11 years of ivermectin mass treatment. No evidence of microfilariae in the cornea and/or anterior chamber of the eye or in skin snips was seen in residents examined in 2006 in two sentinel communities (upper limit of the 95% confidence interval [UL 95% CI] = 0.5% and 0.3%, respectively). In children 10 and under, 0 of 305 were found to harbor antibodies to Ov16, a marker of parasite exposure; 0 of 4,400 Simulium ochraceum s.l. collected in 2005 contained parasite DNA, giving an UL 95% CI for the infective rate of 0.9/2,000, and an UL 95% CI of the seasonal transmission potential of 1.2 L3/person. These data, assumed to be representative of the focus as a whole, suggest that there is no ongoing transmission of Onchocerca volvulus in the northern Chiapas focus. Community-wide treatments with ivermectin were halted in 2008, and a post-treatment surveillance phase was initiated.
北部恰帕斯州盘尾丝虫病流行区已进行了 11 年的伊维菌素群体治疗。2006 年在两个哨点社区对居民进行检查时,未发现角膜和/或眼前房以及皮肤切片中有微丝蚴;在 10 岁及以下的儿童中,305 名儿童中未发现有针对 Ov16 的抗体(寄生虫暴露的标志物);2005 年采集的 4400 只橙色伊蚊 s.l.中未发现寄生虫 DNA,这意味着感染率的上限为每 2000 人中有 0.9 例,季节性传播潜力的上限为每人 1.2 条 L3。这些数据被认为代表整个流行区的情况,表明北部恰帕斯州流行区目前不存在盘尾丝虫的传播。2008 年停止了针对整个社区的伊维菌素治疗,并开始了治疗后监测阶段。